Results 31 to 40 of about 1,663,571 (298)

HEMAGGLUTINATION AND HEMOLYSIS BY ESCHERICHIA COLI ISOLATED FROM CASES OF MASTITIS [PDF]

open access: yesVeterinary Medical Journal - Giza, 1995
A total of 64 isolates of Escherichia coli secured from cases of intramammary infections were tested for their ability to hemagglutinate bovine erythrocytes; of these 37 (58%) were hemagglutination positive. Only 2 of 12 fecal  Escherichia coli isolates (
M AHMED
doaj   +1 more source

High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli [PDF]

open access: yes, 2014
BACKGROUND International travel contributes to the worldwide spread of multidrug resistant Gram-negative bacteria. Rates of travel-related faecal colonization with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae vary for different ...
Battegay, Manuel   +37 more
core   +3 more sources

Antimicrobial Resistance in Escherichia coli Causing Urinary Tract Infection: A Four-Year Study

open access: yesJournal of Pure and Applied Microbiology
Urinary tract infections (UTIs) are among the most frequently encountered infections for which individuals seek medical attention. They are usually ascending infections and if left untreated the causative agent can ascend the ureters causing ...
Anushka V. Devnikar   +5 more
doaj   +1 more source

Transmission and quantification of verocytotoxin-producing Escherichia coli O157 in dairy cattle and calves [PDF]

open access: yes, 2009
Data from a field study of 14 months duration in a naturally colonized dairy herd and data from an experiment with calves were used to quantify transmission of verocytotoxin-producing Escherichia coli (VTEC O157) in cattle.
Schouten, J.M.   +4 more
core   +1 more source

Draft Genome Sequence of an Escherichia coli O157:H43 Strain Isolated from Cattle [PDF]

open access: yes, 2013
Here we report the draft genome sequence of an Escherichia coli O157:H43 strain, designated T22, with an atypical virulence gene profile and isolated from healthy cattle.
Maróti, Gergely   +4 more
core   +1 more source

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

open access: yesFEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

SbcCD regulation and localization in Escherichia coli [PDF]

open access: yes, 2007
The SbcCD complex and its homologues play important roles in DNA repair and in the maintenance of genome stability. In Escherichia coli, the in vitro functions of SbcCD have been well characterized, but its exact cellular role remains elusive.
Helness, Anne C   +7 more
core   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Extended-Spectrum β-Lactamase (ESBL) Genotypes among Multidrug-Resistant Uropathogenic Escherichia coli Clinical Isolates from a Teaching Hospital of Nepal

open access: yesInterdisciplinary Perspectives on Infectious Diseases, 2020
Urinary tract infections (UTI) represent the most common bacterial infections among patients visiting outpatient clinics of healthcare centers in Nepal.
Roshan Pandit   +5 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy